• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 15-12G filed by SeaSpine Holdings Corporation

    1/17/23 4:31:53 PM ET
    $SPNE
    Medical Specialities
    Health Care
    Get the next $SPNE alert in real time by email
    15-12G 1 spne-form15.htm 15-12G Document


    _____________________________________________________________________________________________________________________________________________________________________________________

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    FORM 15
    Certification and Notice of Termination of Registration under Section 12(g) of
    the Securities Exchange Act of 1934 or Suspension of Duty to File Reports Under
    Sections 13 and 15(d) of the Securities Exchange Act of 1934.
    Commission File Number: 001-36905
    SeaSpine Holdings Corporation
    __________________________________________________________________________________________________
    (Exact name of registrant as specified in its charter)
    c/o Orthofix Medical Inc.
    3451 Plano Parkway
    Lewisville, Texas 75056
    (214) 937-2000
    _________________________________________________________________________________________________
    (Address, including zip code, and telephone number, including area code, of registrant's principal executive offices)
    Common stock, $0.01 par value per share
    __________________________________________________________________________________________________
    (Title of each class of securities covered by this Form)
    None
    __________________________________________________________________________________________________
    (Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
    Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
    Rule 12g-4(a)(1)
    x
    Rule 12g-4(a)(2)
    ❑
    Rule 12h-3(b)(1)(i)
    x
    Rule 12h-3(b)(1)(ii)
    ❑
    Rule 15d-6
    ❑
    Rule 15d-22(b)
    ❑

    Approximate number of holders of record as of the certification or notice date: None
    _____________________________________________________________________________________________________________________________________________________________________________________


    _____________________________________________________________________________________________________________________________________________________________________________________


    Pursuant to the requirements of the Securities Exchange Act of 1934, SeaSpine Holdings Corporation has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
    SeaSpine Holdings Corporation
    Date:January 17, 2023By:/s/ Keith Valentine
    Name: Keith Valentine
    Title: President and Chief Executive Officer
    Get the next $SPNE alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $SPNE

    DatePrice TargetRatingAnalyst
    11/2/2022$12.00 → $6.75Buy → Hold
    Truist
    4/22/2022$27.00 → $21.00Overweight
    Cantor Fitzgerald
    4/13/2022$20.00Buy
    Truist
    12/21/2021$25.00 → $20.00Buy
    Truist Securities
    10/28/2021$100.00Buy
    Loop Capital
    More analyst ratings